Dragonfly (Biotechnology) Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 118
Employees
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 5

Dragonfly (Biotechnology) General Information

Description

Developer of cancer therapies intended to stimulate immune responses against cancer. The company is developing novel first-in-class therapeutics targeted at natural killer cells and other cells of the innate immune system, enabling oncologists to identify the early symptoms of cancer and thus initiate treatment quickly.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 35 Gatehouse Drive
  • Waltham, MA 02451
  • United States
+1 (617) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Dragonfly (Biotechnology) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 19-Mar-2020 0000 Completed Generating Revenue
3. Corporate 15-May-2017 0000 0000 Completed Generating Revenue
2. Accelerator/Incubator 17-May-2016 Completed Generating Revenue
1. Angel (individual) 01-Jan-2016 Completed Generating Revenue
To view Dragonfly (Biotechnology)’s complete valuation and funding history, request access »

Dragonfly (Biotechnology) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of cancer therapies intended to stimulate immune responses against cancer. The company is developing novel fir
Biotechnology
Waltham, MA
118 As of 2021
0000
0000000000 0 0000

00000000

e dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur s
0000000000000
Gaithersburg, MD
00 As of 0000
00000
0000 0000-00-00
00000000 00000

00000 00

enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo conseq
0000 000000000
Cambridge, MA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Dragonfly (Biotechnology) Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NexImmune Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
00000 00000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
000000 00000000000 Venture Capital-Backed Redwood City, CA 00 00000 000000000 00000
0000000 000000000 Venture Capital-Backed Cambridge, MA 00 000.00 000000 - 000 000.00
00000 Formerly VC-backed Cambridge, MA 000 00000 000000&0
You’re viewing 5 of 16 competitors. Get the full list »

Dragonfly (Biotechnology) Executive Team (9)

Name Title Board Seat Contact Info
William Haney Co-Founder & Chief Executive Officer
Nicolai Wagtmann Ph.D Chief Scientific Officer
David Raulet Ph.D Co-Founder & Member of Scientific Advisory Board
Tapan Maniar Senior Vice President & Head of Clinical Development
MaryKate Flaherty Vice President of Finance
You’re viewing 5 of 9 executive team members. Get the full list »

Dragonfly (Biotechnology) Board Members (2)

Name Representing Role Since
David Raulet Ph.D Dragonfly (Biotechnology) Co-Founder & Member of Scientific Advisory Board 000 0000
Tyler Jacks Ph.D Self Co-Founder & Chairman, Scientific Advisory Board 000 0000
To view Dragonfly (Biotechnology)’s complete board members history, request access »

Dragonfly (Biotechnology) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dragonfly (Biotechnology) Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Agent Capital Venture Capital Minority 000 0000 000000 0
Fidelity Management & Research Asset Manager Minority 000 0000 000000 0
Celgene Corporation Minority 000 0000 000000 0
JLABS Accelerator/Incubator Minority 000 0000 000000 0
Carica Investments Other Minority 000 0000 000000 0
To view Dragonfly (Biotechnology)’s complete investors history, request access »